On the report
Therapy follows current CDC STI treatment guidelines. Gonococcal resistance arises through mechanisms most multiplex panels do not target, so the report does not infer susceptibility from genotype.
Reportable in all U.S. states. Molecular detection does not replace public-health reporting.
What the report shows for Neisseria gonorrhoeae
- Detected or not detected, with Ct, limit of detection and cycles above LOD — see PCR reporting.
- A short pathogen summary, including colonizer likelihood where it applies.
- No antibacterial grades — the report identifies the organism and points to guideline management instead.
- When not detected, it is still listed among targets tested.
Tagged
Decision support only. The treating clinician decides. Molecular genotype does not replace phenotypic susceptibility testing, culture, or public-health reporting. Absence of a detected resistance gene does not establish susceptibility. Organism targets vary by panel; CORE-ABR is configured to the assay each laboratory runs.